创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

于瑞河, 戚微岩, 刘晨, 高新梅, 徐寒梅. 离子通道类镇痛药物作用机制及研究进展[J]. 药学进展, 2020, 44(1): 56-65.
引用本文: 于瑞河, 戚微岩, 刘晨, 高新梅, 徐寒梅. 离子通道类镇痛药物作用机制及研究进展[J]. 药学进展, 2020, 44(1): 56-65.
YU Ruihe, QI Weiyan, LIU Chen, GAO Xinmei, XU Hanmei. Mechanisms of Ion Channel-Targeting Analgesic Drugs and Related Research Progress[J]. Progress in Pharmaceutical Sciences, 2020, 44(1): 56-65.
Citation: YU Ruihe, QI Weiyan, LIU Chen, GAO Xinmei, XU Hanmei. Mechanisms of Ion Channel-Targeting Analgesic Drugs and Related Research Progress[J]. Progress in Pharmaceutical Sciences, 2020, 44(1): 56-65.

离子通道类镇痛药物作用机制及研究进展

Mechanisms of Ion Channel-Targeting Analgesic Drugs and Related Research Progress

  • 摘要: 疼痛普遍存在于人类与多种动物中,其机制较为复杂,并影响广泛。目前的疗法通常无法达到预期的疗效和耐受性,因此疼痛的有效治疗仍然是一个挑战。对离子通道信号转导的调节,已经展现出良好的镇痛优势。然而,人类基因组中存在的215个离子通道,其中仅85个离子通道与疼痛有明显联系,且仅少数可用于疼痛的治疗。综述目前在研的离子通道类药物作用机制及最新研究进展。

     

    Abstract: Humans and most animals can have the feeling of pain which is caused by complex mechanisms and has a wide range of influences. Current therapeutics often fail to achieve the desired efficacy and tolerability, leaving the effective treatment of pain remains a challenge. Presently, modulation of ion channel signaling has shown its analgesic advantage. However, among the 215 ion channels in human genome, only 85 of them are strongly associated with pain, and only a few are useful for pain treatment. Here we focused on the latest advances in research of mechanisms of ion channel-targeting analgesic drugs.

     

/

返回文章
返回